|
|
|
42
|
4463F
|
YASNAL Q 5MG TAB (KRK) DONEPEZIL
|
DONEPEZIL
|
YASNAL Q
|
28'S
|
C
|
30.09
|
1.07
|
TAB
|
30
|
BLIS
|
KRK
|
KRKA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
41
|
4463G
|
RIVASTIGMINE 4.5MG CAP (KWA) (C)
|
RIVASTIGMINE
|
RIVASTIGMINE
|
60'S
|
C
|
99.82
|
1.6636
|
CAP
|
30
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
4463J
|
RIVASTIGMINE 4.5MG TAB (DRL/AHI)
|
RIVASTIGMINE
|
RIVASTIGMINE
|
60'S
|
C
|
96.69
|
1.61
|
TABLET
|
0
|
CAP
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
4463M
|
DONEPEZIL 5MG TAB (JUB/AHI)
|
DONEPEZIL
|
DONEPEZIL
|
90'S
|
A
|
25.82
|
0.29
|
TABLET
|
30
|
TAB
|
JUB
|
JUBILANT LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
deleted from Contract
|
Oral
|
6
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
4463M
|
DONEPEZIL 5MG TAB (JUB/AHI)
|
DONEPEZIL
|
DONEPEZIL
|
90'S
|
A
|
25.82
|
0.29
|
TABLET
|
30
|
TAB
|
JUB
|
JUBILANT LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
deleted from Contract
|
Oral
|
6
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
4463N
|
DONEPEZIL 5MG TAB (CIP/AHI)
|
DONEPEZIL
|
DONEPEZIL
|
4X7'S
|
A
|
8.05
|
0.2875
|
TABLET IMMED
|
30
|
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-11-29
|
2024-03-31
|
Add to Contract as Cat A
|
oral
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-11-29
|
|
|
|
42
|
4463W
|
DONEMAX 5MG TAB (JLP) DONEPEZIL
|
DONEPEZIL
|
DONEMAX
|
10X10
|
A
|
21.47
|
0.21
|
TAB
|
30
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
44642
|
ARICEPT 10MG TAB (PFI/STO) DONEPEZIL
|
DONEPEZIL
|
ARICEPT
|
28'S
|
C
|
144.45
|
5.16
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
44642
|
ARICEPT 10MG TAB (PFI) DONEPEZIL (C)
|
DONEPEZIL
|
ARICEPT
|
28'S
|
C
|
128.55
|
4.5911
|
TAB
|
30
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
42
|
44642
|
ARICEPT 10MG TAB (PFI) DONEPEZIL
|
DONEPEZIL
|
ARICEPT
|
28'S
|
C
|
128.55
|
4.59
|
TAB
|
30
|
BLIS
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
4464A
|
APO-DONEPEZIL 10MG TAB (APO/COL) DONEPEZIL
|
DONEPEZIL
|
APO-DONEPEZIL
|
100'S
|
A
|
95.14
|
0.95
|
TABLET
|
30
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
4464E
|
YASNAL Q DISP 10MG TAB (KRK/AHI) DONEPEZIL
|
DONEPEZIL
|
YASNAL Q DISP
|
28'S
|
C
|
47.57
|
1.70
|
TABLET
|
0
|
TAB
|
KRK
|
KRKA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
4464E
|
YASNAL Q DISP 10MG TAB (KRK/AHI) DONEPEZIL
|
DONEPEZIL
|
YASNAL Q DISP
|
28'S
|
A
|
47.57
|
1.70
|
TABLET
|
30
|
TAB
|
KRK
|
KRKA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-06-17
|
2022-09-30
|
|
Oral
|
6
|
AUTONOMIC DRUGS
|
2022-06-17
|
|
|
|
41
|
4464E
|
YASNAL Q 10MG DISP TAB (KRK) DONEPEZIL (C)
|
DONEPEZIL
|
YASNAL Q
|
28'S
|
C
|
47.57
|
1.699
|
TABDISP
|
0
|
BOX
|
KRK
|
KRKA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
42
|
4464E
|
YASNAL Q 10MG DISP TAB (KRK) DONEPEZIL
|
DONEPEZIL
|
YASNAL Q
|
28'S
|
C
|
47.57
|
1.70
|
TABDISP
|
0
|
BLIS
|
KRK
|
KRKA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
4464K
|
RIVASTIGMINE 6MG CAP (DRL/AHI)
|
RIVASTIGMINE
|
RIVASTIGMINE
|
60'S
|
C
|
107.32
|
1.79
|
CAPSULE
|
0
|
CAP
|
DRL
|
DR. REDDY'S LABORATORIES LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
4464P
|
PMS-DONEPEZIL 10MG TAB (PMS)
|
DONEPEZIL
|
PMS-DONEPEZIL
|
100'S
|
A
|
53.01
|
0.5301
|
TAB
|
30
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
42
|
4464P
|
PMS-DONEPEZIL 10MG TAB (PMS)
|
DONEPEZIL
|
PMS-DONEPEZIL
|
100'S
|
A
|
40.77
|
0.41
|
TAB
|
30
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
AVENTA BARBADOS
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
42
|
4464S
|
DONEMAX 10MG TAB (JLP) DONEPEZIL
|
DONEPEZIL
|
DONEMAX
|
10X10
|
A
|
24.19
|
0.24
|
TAB
|
30
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
4582A
|
BERIATE 500IU INJ (CSL/AHI) FACTOR VIII
|
FACTOR VIII
|
BERIATE
|
10ML VIAL
|
BQ
|
244.65
|
244.65
|
INJECTION
|
0
|
VIAL
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|